Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 179162-64-2 | MDL No. : | MFCD17014817 |
Formula : | C22H23NO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | JLCLOAYOQLRDSK-UHFFFAOYSA-N |
M.W : | 365.42 | Pubchem ID : | 10737571 |
Synonyms : |
|
Num. heavy atoms : | 27 |
Num. arom. heavy atoms : | 17 |
Fraction Csp3 : | 0.27 |
Num. rotatable bonds : | 9 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 104.37 |
TPSA : | 61.56 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -4.76 cm/s |
Log Po/w (iLOGP) : | 4.4 |
Log Po/w (XLOGP3) : | 5.31 |
Log Po/w (WLOGP) : | 5.36 |
Log Po/w (MLOGP) : | 3.24 |
Log Po/w (SILICOS-IT) : | 5.44 |
Consensus Log Po/w : | 4.75 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -5.32 |
Solubility : | 0.00174 mg/ml ; 0.00000476 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -6.35 |
Solubility : | 0.000162 mg/ml ; 0.000000442 mol/l |
Class : | Poorly soluble |
Log S (SILICOS-IT) : | -8.04 |
Solubility : | 0.00000329 mg/ml ; 0.000000009 mol/l |
Class : | Poorly soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 3.0 |
Synthetic accessibility : | 3.35 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P301+P312-P302+P352-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 179162-55-1 ]
4-(5-(4-(Pentyloxy)phenyl)isoxazol-3-yl)benzoic acid
Similarity: 0.96
[ 745055-49-6 ]
3-(3-(4-(2-Methoxyethoxy)phenyl)isoxazol-5-yl)benzoic acid
Similarity: 0.90
[ 142967-38-2 ]
3,5-Bis(3,5-bis(decyloxy)phenyl)isoxazole
Similarity: 0.83
[ 140866-44-0 ]
3,5-Bis(4-(hex-5-en-1-yloxy)phenyl)isoxazole
Similarity: 0.83
[ 179162-55-1 ]
4-(5-(4-(Pentyloxy)phenyl)isoxazol-3-yl)benzoic acid
Similarity: 0.96
[ 745055-49-6 ]
3-(3-(4-(2-Methoxyethoxy)phenyl)isoxazol-5-yl)benzoic acid
Similarity: 0.90
[ 142967-38-2 ]
3,5-Bis(3,5-bis(decyloxy)phenyl)isoxazole
Similarity: 0.83
[ 140866-44-0 ]
3,5-Bis(4-(hex-5-en-1-yloxy)phenyl)isoxazole
Similarity: 0.83
[ 179162-55-1 ]
4-(5-(4-(Pentyloxy)phenyl)isoxazol-3-yl)benzoic acid
Similarity: 0.96
[ 745055-49-6 ]
3-(3-(4-(2-Methoxyethoxy)phenyl)isoxazol-5-yl)benzoic acid
Similarity: 0.90
[ 142967-38-2 ]
3,5-Bis(3,5-bis(decyloxy)phenyl)isoxazole
Similarity: 0.83
[ 140866-44-0 ]
3,5-Bis(4-(hex-5-en-1-yloxy)phenyl)isoxazole
Similarity: 0.83